|4Jun 17, 4:01 PM ET

Fitzgerald Thomas A 4

4 · Transcode Therapeutics, Inc. · Filed Jun 17, 2022

Insider Transaction Report

Form 4
Period: 2022-06-16
Fitzgerald Thomas A
DirectorVP, Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-06-16$1.27/sh+12,000$15,240139,377 total

Documents

1 file
  • 4
    tm2218778-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT